New LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market

Global biotech start-ups and affiliated partner organizations will have access to the Boston and Cambridge ecosystem in Kendall Square to forge cross-border collaboration through networking, education, and programming

BOSTON, Sept. 8, 2026 /PRNewswire/ -- LabCentral recently announced the launch of The Loop, a new soft-landing program that provides high-potential global biotech companies developing therapies to address unmet medical needs with accelerated access to the U.S. ecosystem.

Global start-ups will sharpen their value propositions and accelerate their U.S. market-entry through intentional networking and focused cross-border collaboration without the commitment to a full relocation. The program is designed for participants to bring their learnings from Kendall Square back home. This first-of-its-kind offering at LabCentral allows international founders to join the resident community without the obligation of renting lab space.

"Breakthroughs happen when people and ideas come together and build those meaningful connections, and in an ever-expanding global biotech ecosystem it's critical to link and build internationally. Our goal with The Loop is to create more than an introduction - we want to create a pathway into the local biotech community, giving international founders the opportunity to build lasting relationships with investors, partners, advisors, and fellow entrepreneurs," said Maggie O'Toole, CEO of LabCentral.

A cornerstone of the programming is The Loop Week Summit, happening from September 14 – September 18, 2026. Participants from around the world will spend the week immersed in LabCentral's ecosystem with concentrated exposure to the Boston life sciences industry.

In attendance will be representatives from over 20 companies across 10 countries, including Japan, South Korea, Denmark, Taiwan, Czech Republic, Canada, India, Greece, Ireland, and Hong Kong. Additional programming components available to participants of The Loop include:

• Executive Residency for up to 90-days in-person office residency at LabCentral
• Executive Education with exclusive courses led by seasoned entrepreneurs who also serve as faculty at Harvard
• Mentorship & Pitch Coaching with targeted guidance on strengthening U.S. value proposition
• Dedicated Programming Day spotlighting partnering opportunities between delegations and the LabCentral network

A Seoul Biohub official said the program "gives Korean biotech start-ups the opportunity to build real relationships with key players in the Boston ecosystem — the world's largest life sciences market — without taking on the enormous cost and risk of fully relocating to the U.S.," adding that it "will serve as a meaningful springboard for Korean biotech companies approaching technology partnering deals."

The Loop Program Partners represent both public and privately held economic development organizations from various countries in Europe and Asia, adept at identifying high potential start-ups that would benefit from an immersion experience with LabCentral's ecosystem and expertise.

"We are pleased to celebrate the launch of the LabCentral Loop Program. Strengthening connections between Asian entrepreneurs and the Boston biotech ecosystem is essential to advancing life science innovation, and we believe the Loop Program will provide meaningful opportunities for emerging start-ups to grow on a global stage," remarked Toshio Fujimoto, CEO, iPark Institute Co., Ltd.

Along with Shonan iPark in Japan, additional partners include Innovation Centre Denmark – Boston, Seoul BioHub, Hong Kong Science & Technology Park, Quebec Government Office in Boston, IOCB Tech, and other start-up support organizations.

"…By connecting these companies with the knowledge, networks and resources of the Greater Boston ecosystem, the program can help accelerate their international growth, strengthen their global ambitions, and bring valuable experience and connections back to Denmark," said Ann-Christina Lange, Consul General of Denmark & Executive Director, Innovation Centre Denmark Boston

For more information on how you can get involved, visit our website.

ABOUT LABCENTRAL
A private, non-profit institution, LabCentral is a launchpad for high-potential life sciences and biotech start-ups with more than 200,000 square feet of space across Kendall Square in Cambridge, Mass., and the Harvard University campus. Founded in 2013, LabCentral offers a full complement of programming and networking to life sciences entrepreneurs in addition to fully permitted laboratory and office space for early-stage and growing life sciences companies. In its first twelve years, LabCentral residents raised more than $21 billion in funding and created more than 7,800 jobs. More information is available at www.labcentral.org. 

SOURCE LabCentral